Cited by 1,707Infective Endocarditis Diagnosis and ManagementStreptococcal Infections and TreatmentsCardiac Valve Diseases and Treatments

Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America

Open access
Baddour, Larry M., Wilson, Walter R., Bayer, Arnold S., Fowler, Vance G., Bolger, Ann F., Levison, Matthew E., Ferrieri, Patricia, Gerber, Michael A. +12 more·2005·Circulation

Abstract

Background— Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness. Methods and Results— This work represents the third iteration of an infective endocarditis “treatment” document developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It updates recommendations for diagnosis, treatment, and management of complications of infective endocarditis. A multidisciplinary committee of experts drafted this document to assist physicians in the evolving care of patients with infective endocarditis in the new millennium. This extensive document is accompanied by an executive summary that covers the key points of the diagnosis, antimicrobial therapy, and management of infective endocarditis. For the first time, an evidence-based scoring system that is used by the American College of Cardiology and the American Heart Association was applied to treatment recommendations. Tables also have been included that provide input on the use of echocardiography during diagnosis and treatment of infective endocarditis, evaluation and treatment of culture-negative endocarditis, and short-term and long-term management of patients during and after completion of antimicrobial treatment. To assist physicians who care for children, pediatric dosing was added to each treatment regimen. Conclusions— The recommendations outlined in this update should assist physicians in all aspects of patient care in the diagnosis, medical and surgical treatment, and follow-up of infective endocarditis, as well as management of associated complications. Clinical variability and complexity in infective endocarditis, however, dictate that these guidelines be used to support and not supplant physician-directed decisions in individual patient management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.105.165564

Cites

286 of 286 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. [25]25. Arguello EA, Varini S, Romorini A, Elizari A, Clara L, Casabe H. Infective endocarditis in the Argentine Republic. Paper presented at: Third International Symposium on Modern Concepts in Endocarditis; July 13-15, 1995; Boston, Mass. Abstract 152A.
  2. [26]26. Kanavos K, Antoniadou A, Venetis C, Gezerlis P, Giamarellou H. Retrospective analysis of Duke's criteria in 60 cases of infective endo- carditis in Greece. Paper presented at: Third International Symposium on Modern Concepts in Endocarditis; July 13-15, 1995; Boston, Mass. Abstract 138.
  3. [65]65. Roberts RB. Streptococcal endocarditis: the viridans and beta-hemolytic streptococci. In: Kaye D, ed. Infective Endocarditis. 2nd ed. New York, NY: Raven Press; 1992:191-208.
  4. [73]73. Cabell CH, Barsic B, Bayer AS, Hoen B, Olaison L, Fowler VG Jr, Miro JM, Chen A, Stafford J, Gordon D, Peterson G, Spelman D, Selton-Suty C, Korman T, Abrutyn E. Clinical findings, complications, and outcomes in a large prospective study of definite endocarditis: the International Collaboration on Endocarditis-Prospective Cohort Study. Paper presented at: 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections; June 26 -28, 2003; Chamonix, France. Abstract 22.
  5. [74]74. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JTM, Elliott TSJ, Levine DP, Bayer AS. Staphylococcus aureus endocarditis throughout the world: a product of medical progress. Report from the ICE Investigators. JAMA. In press.
  6. [75]75. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90 -94.
  7. [86]86. De Hondt G, Ieven M, Vandermersch C, Colaert J. Destructive endo- carditis caused by Staphylococcus lugdunensis: case report and review of the literature. Acta Clin Belg. 1997;52:27-30.
  8. [110]110. Methicillin-resistant Staphylococcus aureus infections among com- petitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000 -2003. Morb MMWR Morb Mortal Wkly Rep. 2003;52:793-795.
  9. [111]111. Outbreaks of community-associated methicillin-resistant Staphylo- coccus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2003;52:88.
  10. [202]202. Rothman RE, Walker T, Weiss J, Majmudar MD, Kelen GD. Diagnostic importance of transthoracic echocardiography in febrile intravenous drug users at risk for infective endocarditis: is there a role for ultrasound in the emergency department? Paper presented at: 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections; June 26 -28, 2003; Chamonix, France. Abstract 66.
  11. [204]204. Carozza A, Romano G, De Feo M, De Santo L, Ragone E, Tripodi MF, Durante Mangoni E, Utili R. Infective endocarditis in intravenous drug users: prevalence of left heart involvement and changing microbiologic profile. Paper presented at: 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections; June 26 -28, 2003; Chamonix, France. Abstract 53.
  12. [216]216. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289:1933-1940.
  13. [262]262. Wilson WR, Lie JT, Houser OW, Piepgras DG, Geraci JE. The man- agement of patients with mycotic aneurysm. Curr Clin Top Infect Dis. 1981;2:151-183.
  14. [264]264. Bohmfalk GL, Story JL, Wissinger JP, Brown WE Jr. Bacterial intra- cranial aneurysm. J Neurosurg. 1978;48:369 -382.
  15. [266]266. Camarata PJ, Latchaw RE, Rufenacht DA, Heros RC. Intracranial an- eurysms. Invest Radiol. 1993;28:373-382.

Cited by

Sorted by citations

Authors
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., Tong, D. C., Steckelberg, J. M., Baltimore, R. S., Shulman, S. T., Burns, J. C., Falace, D. A., Newburger, J. W., Pallasch, T. J., Takahashi, M., & Taubert, K. A.
Affiliations
American Heart Association (US)
Venue
Circulation
Published
2005-06-14
Volume
111
Issue
23
Pages
e394-434
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2118546214
Cited by
1,707
References
286
Citations by year
2026: 7 · 2025: 17 · 2024: 22 · 2023: 22 · 2022: 16 · 2021: 30 · 2020: 49 · 2019: 56 · 2018: 44 · 2017: 69 · 2016: 96 · 2015: 141 · 2014: 154 · 2013: 153 · 2012: 124
FWCI
69.32
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • Bristol-Myers Squibb
  • Sanofi
  • Yale University
  • University of Southern California
  • Children's Hospital Los Angeles
  • Cincinnati Children's Hospital Medical Center
  • Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago
  • University of Minnesota
  • Drexel University
  • School of Medicine
Topics
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
Keywords
infective endocarditis, antimicrobial therapy, antimicrobial resistance, culture-negative endocarditis, echocardiography, endocarditis complications, pediatric dosing, treatment guidelines
MeSH terms
Ambulatory Care, American Heart Association, Anti-Infective Agents, Bacteria, Cardiovascular Diseases, Echocardiography, Endocarditis, Bacterial, Humans, Evidence-Based Medicine, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review